Search Results - "Aderka, D"

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers by Golan, T, Kanji, Z S, Epelbaum, R, Devaud, N, Dagan, E, Holter, S, Aderka, D, Paluch-Shimon, S, Kaufman, B, Gershoni-Baruch, R, Hedley, D, Moore, M J, Friedman, E, Gallinger, S

“…Background: The BRCA1/2 proteins are involved in regulation of cellular proliferation by DNA damage repair via homologous recombination. Therefore, BRCA1/2…”
Get full text

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer by Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J.H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J.-Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V., Hoff, P., Köhne, C.-H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., Österlund, P., Oyen, W.J.G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T.J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H.J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A., Arnold, D.

“…Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical…”
Get full text

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial by Stintzing, S., Wirapati, P., Lenz, H.-J., Neureiter, D., Fischer von Weikersthal, L., Decker, T., Kiani, A., Kaiser, F., Al-Batran, S., Heintges, T., Lerchenmüller, C., Kahl, C., Seipelt, G., Kullmann, F., Moehler, M., Scheithauer, W., Held, S., Modest, D.P., Jung, A., Kirchner, T., Aderka, D., Tejpar, S., Heinemann, V.

“…FIRE-3 compared first-line therapy with FOLFIRI plus either cetuximab or bevacizumab in 592 KRAS exon 2 wild-type metastatic colorectal cancer (mCRC) patients…”
Get full text

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making by Schmoll, H.J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C.J., Balmana, J., Regula, J., Nagtegaal, I.D., Beets-Tan, R.G., Arnold, D., Ciardiello, F., Hoff, P., Kerr, D., Köhne, C.H., Labianca, R., Price, T., Scheithauer, W., Sobrero, A., Tabernero, J., Aderka, D., Barroso, S., Bodoky, G., Douillard, J.Y., El Ghazaly, H., Gallardo, J., Garin, A., Glynne-Jones, R., Jordan, K., Meshcheryakov, A., Papamichail, D., Pfeiffer, P., Souglakos, I., Turhal, S., Cervantes, A.

“…Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation…”
Get full text

Prolonged overall survival of metastatic gastric cancer patients with BRCA germline mutations by Halpern, N., Grinshpun, A., Boursi, B., Golan, T., Margalit, O., Aderka, D., Laitman, Y., Friedman, E., Hubert, A., Peretz, T., Hamburger, T., Kedar-Barnes, I., Levi, Z., Ben-Aharon, I., Goldberg, Y., Shacham-Shmueli, E.

Get full text

P-146Colorectal cancer patients with lung-only metastases have a favorable prognosis irrespective of treatment by Gadot, M, Lawrence, Y, Aderka, D, Golan, T, Shani, A, Halpern, N, Margalit, O, Shmueli, E

Get full text

709. Metastases to surgical scars from primary operation for intraabdominal malignancies, revisited during secondary cytoreductive surgery for recurrent peritoneal disease by Dux, J, Rayman, S, Shachar, Y, Adileh, M, Shapiro, R, Zippel, D, Ben-Yaakov, A, Shacham-Shmueli, E, Aderka, D, Venturero, M, Nissan, A

Get full text

117. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of peritoneal surface malignancies in the elderly by Dux, J, Rayman, S, Zendel, A, Segev, L, Hoffman, A, Ben Yaacov, A, Marom, G, Aderka, D, Shacham Shmueli, E, Beny, A, Ayala, H, Grenader, T, Brenner, B, Purim, O, Gutman, M, Venturero, M, Nissan, A

Get full text

IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice by Aderka, D, Le, JM, Vilcek, J

“…Incubation of the human U937 histiocytic lymphoma cell line with granulocyte-macrophage colony stimulating factor (GM-CSF) rendered the cells responsive to…”
Get full text

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors by ADERKA, D, ENGELMANN, H, MAOR, Y, BRAKEBUSCH, C, WALLACH, D

“…The receptors for tumor necrosis factor (TNF) exist in cell-associated as well as soluble forms, both binding specifically to TNF. Since the soluble forms of…”
Get full text

PET/CT detects abdominal wall and port site metastases of colorectal carcinoma by GOSHEN, E, DAVIDSON, T, ADERKA, D, ZWAS, S. T

“…Abdominal wall metastases from colorectal cancer (CRC) may be resected with curative results. Such lesions, often indicators of additional intra-abdominal…”
Get full text

Elevated tumour necrosis factor‐alpha (TNF‐α) biological activity in psoriatic skin lesions by ETTEHADI, P., GREAVES, M. W., WALLACH, D., ADERKA, D., CAMP, R. D. R.

“…SUMMARY Lesions of the common inflammatory skin disease psoriasis are characterized by epidermal hyperproliferation, leucocyte adhesion molecule expression and…”
Get full text

A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity by Engelmann, H, Aderka, D, Rubinstein, M, Rotman, D, Wallach, D

“…Unfractionated preparations of the proteins of human urine provided protection against the in vitro cytocidal effect of tumor necrosis factor (TNF). In certain…”
Get full text

Does Concurrent Chemoradiotherapy Compromise the Delivery of Subsequent Sequential Gemcitabine in Locally Advanced Pancreatic Cancer? by Symon, Z, Rabin, T, Kundel, Y, Gluck, I, Wolf, I, Aderka, D, Ben-David, M, Catane, R, Pfeffer, M

Get full text

Primary papillary serous carcinoma of the peritoneum in a man by Shmueli, E., Leider-Trejo, L., Schwartz, I., Aderka, D., Inbar, M.

“…Background Primary papillary serous carcinoma of the peritoneum is a well-known entity in women The tumour is derived from the extraovarian mesothehum and the…”
Get full text

Soluble forms of tumor necrosis factor receptors (TNF‐Rs). The cDNA for the type I TNF‐R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor by Nophar, Y., Kemper, O., Brakebusch, C., Englemann, H., Zwang, R., Aderka, D., Holtmann, H., Wallach, D.

“…Two proteins which specifically bind tumor necrosis factor (TNF) have recently been isolated from human urine in our laboratory. The two proteins cross‐react…”
Get full text

Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock by Aderka, D, Sorkine, P, Abu-Abid, S, Lev, D, Setton, A, Cope, A P, Wallach, D, Klausner, J

“…We examined the kinetics of shedding of the soluble TNF receptors (TNF-Rs) in response to TNF leakage during isolated limb perfusion procedures and correlated…”
Get full text

417P Early experience in using plasma-only multi-omic minimal residual disease testing in early-stage colorectal cancer patients from Asia and the Middle East by Dawood, S., Jain, S.S., Lavingia, V., Aderka, D., Tahover, E., Temper, M., Goldman, A., Al Akasheh, M., Olsen, S., Hsing, S., Joshi, N.

Get full text

SO-28 Effect of prior bevacizumab treatment in BRAF V600E-mutant metastatic colorectal cancer: Overall survival with encorafenib + cetuximab +/- binimetinib in BEACON CRC by Aderka, D., Kopetz, S., Grothey, A., Van Cutsem, E., Yaeger, R., Wasan, H., Yoshino, T., Desai, J., Ciardiello, F., Golden, A., Edwards, M., Tabernero, J.

Get full text

Tumor necrosis factor induction by Sendai virus by Aderka, D, Holtmann, H, Toker, L, Hahn, T, Wallach, D

“…Supernatants of peripheral blood mononuclear leukocytes (PBMC) treated with Sendai virus were found to exert significant cytotoxic effects mediated by…”
Get full text